Global Dental Engine Market
As the global economy mends, the 2021 growth of Dental Engine will have significant change from p ... Read More
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global TB Disease Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for TB Disease Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for TB Disease Vaccine by Country/Region, 2017, 2022 & 2028 2.2 TB Disease Vaccine Segment by Type 2.2.1 Prevention Vaccines 2.2.2 Post-exposure Vaccines 2.2.3 Others 2.3 TB Disease Vaccine Sales by Type 2.3.1 Global TB Disease Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global TB Disease Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global TB Disease Vaccine Sale Price by Type (2017-2022) 2.4 TB Disease Vaccine Segment by Application 2.4.1 Self-Procurement 2.4.2 UNICEF 2.4.3 Others 2.5 TB Disease Vaccine Sales by Application 2.5.1 Global TB Disease Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global TB Disease Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global TB Disease Vaccine Sale Price by Application (2017-2022) 3 Global TB Disease Vaccine by Company 3.1 Global TB Disease Vaccine Breakdown Data by Company 3.1.1 Global TB Disease Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global TB Disease Vaccine Sales Market Share by Company (2020-2022) 3.2 Global TB Disease Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global TB Disease Vaccine Revenue by Company (2020-2022) 3.2.2 Global TB Disease Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global TB Disease Vaccine Sale Price by Company 3.4 Key Manufacturers TB Disease Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers TB Disease Vaccine Product Location Distribution 3.4.2 Players TB Disease Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for TB Disease Vaccine by Geographic Region 4.1 World Historic TB Disease Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global TB Disease Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global TB Disease Vaccine Annual Revenue by Geographic Region 4.2 World Historic TB Disease Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global TB Disease Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global TB Disease Vaccine Annual Revenue by Country/Region 4.3 Americas TB Disease Vaccine Sales Growth 4.4 APAC TB Disease Vaccine Sales Growth 4.5 Europe TB Disease Vaccine Sales Growth 4.6 Middle East & Africa TB Disease Vaccine Sales Growth 5 Americas 5.1 Americas TB Disease Vaccine Sales by Country 5.1.1 Americas TB Disease Vaccine Sales by Country (2017-2022) 5.1.2 Americas TB Disease Vaccine Revenue by Country (2017-2022) 5.2 Americas TB Disease Vaccine Sales by Type 5.3 Americas TB Disease Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC TB Disease Vaccine Sales by Region 6.1.1 APAC TB Disease Vaccine Sales by Region (2017-2022) 6.1.2 APAC TB Disease Vaccine Revenue by Region (2017-2022) 6.2 APAC TB Disease Vaccine Sales by Type 6.3 APAC TB Disease Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe TB Disease Vaccine by Country 7.1.1 Europe TB Disease Vaccine Sales by Country (2017-2022) 7.1.2 Europe TB Disease Vaccine Revenue by Country (2017-2022) 7.2 Europe TB Disease Vaccine Sales by Type 7.3 Europe TB Disease Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa TB Disease Vaccine by Country 8.1.1 Middle East & Africa TB Disease Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa TB Disease Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa TB Disease Vaccine Sales by Type 8.3 Middle East & Africa TB Disease Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of TB Disease Vaccine 10.3 Manufacturing Process Analysis of TB Disease Vaccine 10.4 Industry Chain Structure of TB Disease Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 TB Disease Vaccine Distributors 11.3 TB Disease Vaccine Customer 12 World Forecast Review for TB Disease Vaccine by Geographic Region 12.1 Global TB Disease Vaccine Market Size Forecast by Region 12.1.1 Global TB Disease Vaccine Forecast by Region (2023-2028) 12.1.2 Global TB Disease Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global TB Disease Vaccine Forecast by Type 12.7 Global TB Disease Vaccine Forecast by Application 13 Key Players Analysis 13.1 Merck 13.1.1 Merck Company Information 13.1.2 Merck TB Disease Vaccine Product Offered 13.1.3 Merck TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Merck Main Business Overview 13.1.5 Merck Latest Developments 13.2 Japan BCG Lab 13.2.1 Japan BCG Lab Company Information 13.2.2 Japan BCG Lab TB Disease Vaccine Product Offered 13.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Japan BCG Lab Main Business Overview 13.2.5 Japan BCG Lab Latest Developments 13.3 Serum Institute of India 13.3.1 Serum Institute of India Company Information 13.3.2 Serum Institute of India TB Disease Vaccine Product Offered 13.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Serum Institute of India Main Business Overview 13.3.5 Serum Institute of India Latest Developments 13.4 AJ Vaccines 13.4.1 AJ Vaccines Company Information 13.4.2 AJ Vaccines TB Disease Vaccine Product Offered 13.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 AJ Vaccines Main Business Overview 13.4.5 AJ Vaccines Latest Developments 13.5 BioFarma 13.5.1 BioFarma Company Information 13.5.2 BioFarma TB Disease Vaccine Product Offered 13.5.3 BioFarma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 BioFarma Main Business Overview 13.5.5 BioFarma Latest Developments 13.6 GreenSignal Bio Pharma 13.6.1 GreenSignal Bio Pharma Company Information 13.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Offered 13.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 GreenSignal Bio Pharma Main Business Overview 13.6.5 GreenSignal Bio Pharma Latest Developments 13.7 China National Biotec 13.7.1 China National Biotec Company Information 13.7.2 China National Biotec TB Disease Vaccine Product Offered 13.7.3 China National Biotec TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 China National Biotec Main Business Overview 13.7.5 China National Biotec Latest Developments 13.8 Biomed Lublin 13.8.1 Biomed Lublin Company Information 13.8.2 Biomed Lublin TB Disease Vaccine Product Offered 13.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Biomed Lublin Main Business Overview 13.8.5 Biomed Lublin Latest Developments 13.9 Taj Pharmaceuticals 13.9.1 Taj Pharmaceuticals Company Information 13.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Offered 13.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Taj Pharmaceuticals Main Business Overview 13.9.5 Taj Pharmaceuticals Latest Developments 13.10 Ataulpho de Paiva 13.10.1 Ataulpho de Paiva Company Information 13.10.2 Ataulpho de Paiva TB Disease Vaccine Product Offered 13.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Ataulpho de Paiva Main Business Overview 13.10.5 Ataulpho de Paiva Latest Developments 13.11 IVAC 13.11.1 IVAC Company Information 13.11.2 IVAC TB Disease Vaccine Product Offered 13.11.3 IVAC TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 IVAC Main Business Overview 13.11.5 IVAC Latest Developments 13.12 Queen Saovabha Mem. Inst 13.12.1 Queen Saovabha Mem. Inst Company Information 13.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Offered 13.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Queen Saovabha Mem. Inst Main Business Overview 13.12.5 Queen Saovabha Mem. Inst Latest Developments 13.13 Microgen 13.13.1 Microgen Company Information 13.13.2 Microgen TB Disease Vaccine Product Offered 13.13.3 Microgen TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Microgen Main Business Overview 13.13.5 Microgen Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. TB Disease Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. TB Disease Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Prevention Vaccines Table 4. Major Players of Post-exposure Vaccines Table 5. Major Players of Others Table 6. Global TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 7. Global TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 8. Global TB Disease Vaccine Revenue by Type (2017-2022) & ($ million) Table 9. Global TB Disease Vaccine Revenue Market Share by Type (2017-2022) Table 10. Global TB Disease Vaccine Sale Price by Type (2017-2022) & (US$/Unit) Table 11. Global TB Disease Vaccine Sales by Application (2017-2022) & (K Units) Table 12. Global TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 13. Global TB Disease Vaccine Revenue by Application (2017-2022) Table 14. Global TB Disease Vaccine Revenue Market Share by Application (2017-2022) Table 15. Global TB Disease Vaccine Sale Price by Application (2017-2022) & (US$/Unit) Table 16. Global TB Disease Vaccine Sales by Company (2020-2022) & (K Units) Table 17. Global TB Disease Vaccine Sales Market Share by Company (2020-2022) Table 18. Global TB Disease Vaccine Revenue by Company (2020-2022) ($ Millions) Table 19. Global TB Disease Vaccine Revenue Market Share by Company (2020-2022) Table 20. Global TB Disease Vaccine Sale Price by Company (2020-2022) & (US$/Unit) Table 21. Key Manufacturers TB Disease Vaccine Producing Area Distribution and Sales Area Table 22. Players TB Disease Vaccine Products Offered Table 23. TB Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global TB Disease Vaccine Sales by Geographic Region (2017-2022) & (K Units) Table 27. Global TB Disease Vaccine Sales Market Share Geographic Region (2017-2022) Table 28. Global TB Disease Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 29. Global TB Disease Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 30. Global TB Disease Vaccine Sales by Country/Region (2017-2022) & (K Units) Table 31. Global TB Disease Vaccine Sales Market Share by Country/Region (2017-2022) Table 32. Global TB Disease Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 33. Global TB Disease Vaccine Revenue Market Share by Country/Region (2017-2022) Table 34. Americas TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 35. Americas TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 36. Americas TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 37. Americas TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 38. Americas TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 39. Americas TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 40. Americas TB Disease Vaccine Sales by Application (2017-2022) & (K Units) Table 41. Americas TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 42. APAC TB Disease Vaccine Sales by Region (2017-2022) & (K Units) Table 43. APAC TB Disease Vaccine Sales Market Share by Region (2017-2022) Table 44. APAC TB Disease Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 45. APAC TB Disease Vaccine Revenue Market Share by Region (2017-2022) Table 46. APAC TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 47. APAC TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 48. APAC TB Disease Vaccine Sales by Application (2017-2022) & (K Units) Table 49. APAC TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 50. Europe TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 51. Europe TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 52. Europe TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 53. Europe TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 54. Europe TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 55. Europe TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 56. Europe TB Disease Vaccine Sales by Application (2017-2022) & (K Units) Table 57. Europe TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 58. Middle East & Africa TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 59. Middle East & Africa TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 60. Middle East & Africa TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 61. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 62. Middle East & Africa TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 63. Middle East & Africa TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 64. Middle East & Africa TB Disease Vaccine Sales by Application (2017-2022) & (K Units) Table 65. Middle East & Africa TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 66. Key Market Drivers & Growth Opportunities of TB Disease Vaccine Table 67. Key Market Challenges & Risks of TB Disease Vaccine Table 68. Key Industry Trends of TB Disease Vaccine Table 69. TB Disease Vaccine Raw Material Table 70. Key Suppliers of Raw Materials Table 71. TB Disease Vaccine Distributors List Table 72. TB Disease Vaccine Customer List Table 73. Global TB Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 74. Global TB Disease Vaccine Sales Market Forecast by Region Table 75. Global TB Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 76. Global TB Disease Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 77. Americas TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 78. Americas TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 79. APAC TB Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 80. APAC TB Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 81. Europe TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 82. Europe TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 83. Middle East & Africa TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 84. Middle East & Africa TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 85. Global TB Disease Vaccine Sales Forecast by Type (2023-2028) & (K Units) Table 86. Global TB Disease Vaccine Sales Market Share Forecast by Type (2023-2028) Table 87. Global TB Disease Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 88. Global TB Disease Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 89. Global TB Disease Vaccine Sales Forecast by Application (2023-2028) & (K Units) Table 90. Global TB Disease Vaccine Sales Market Share Forecast by Application (2023-2028) Table 91. Global TB Disease Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 92. Global TB Disease Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 93. Merck Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 94. Merck TB Disease Vaccine Product Offered Table 95. Merck TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 96. Merck Main Business Table 97. Merck Latest Developments Table 98. Japan BCG Lab Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 99. Japan BCG Lab TB Disease Vaccine Product Offered Table 100. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 101. Japan BCG Lab Main Business Table 102. Japan BCG Lab Latest Developments Table 103. Serum Institute of India Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 104. Serum Institute of India TB Disease Vaccine Product Offered Table 105. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 106. Serum Institute of India Main Business Table 107. Serum Institute of India Latest Developments Table 108. AJ Vaccines Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 109. AJ Vaccines TB Disease Vaccine Product Offered Table 110. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 111. AJ Vaccines Main Business Table 112. AJ Vaccines Latest Developments Table 113. BioFarma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 114. BioFarma TB Disease Vaccine Product Offered Table 115. BioFarma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 116. BioFarma Main Business Table 117. BioFarma Latest Developments Table 118. GreenSignal Bio Pharma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 119. GreenSignal Bio Pharma TB Disease Vaccine Product Offered Table 120. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 121. GreenSignal Bio Pharma Main Business Table 122. GreenSignal Bio Pharma Latest Developments Table 123. China National Biotec Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 124. China National Biotec TB Disease Vaccine Product Offered Table 125. China National Biotec TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 126. China National Biotec Main Business Table 127. China National Biotec Latest Developments Table 128. Biomed Lublin Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 129. Biomed Lublin TB Disease Vaccine Product Offered Table 130. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 131. Biomed Lublin Main Business Table 132. Biomed Lublin Latest Developments Table 133. Taj Pharmaceuticals Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 134. Taj Pharmaceuticals TB Disease Vaccine Product Offered Table 135. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 136. Taj Pharmaceuticals Main Business Table 137. Taj Pharmaceuticals Latest Developments Table 138. Ataulpho de Paiva Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 139. Ataulpho de Paiva TB Disease Vaccine Product Offered Table 140. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 141. Ataulpho de Paiva Main Business Table 142. Ataulpho de Paiva Latest Developments Table 143. IVAC Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 144. IVAC TB Disease Vaccine Product Offered Table 145. IVAC TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 146. IVAC Main Business Table 147. IVAC Latest Developments Table 148. Queen Saovabha Mem. Inst Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 149. Queen Saovabha Mem. Inst TB Disease Vaccine Product Offered Table 150. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 151. Queen Saovabha Mem. Inst Main Business Table 152. Queen Saovabha Mem. Inst Latest Developments Table 153. Microgen Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors Table 154. Microgen TB Disease Vaccine Product Offered Table 155. Microgen TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 156. Microgen Main Business Table 157. Microgen Latest Developments List of Figures Figure 1. Picture of TB Disease Vaccine Figure 2. TB Disease Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global TB Disease Vaccine Sales Growth Rate 2017-2028 (K Units) Figure 7. Global TB Disease Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. TB Disease Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Prevention Vaccines Figure 10. Product Picture of Post-exposure Vaccines Figure 11. Product Picture of Others Figure 12. Global TB Disease Vaccine Sales Market Share by Type in 2021 Figure 13. Global TB Disease Vaccine Revenue Market Share by Type (2017-2022) Figure 14. TB Disease Vaccine Consumed in Self-Procurement Figure 15. Global TB Disease Vaccine Market: Self-Procurement (2017-2022) & (K Units) Figure 16. TB Disease Vaccine Consumed in UNICEF Figure 17. Global TB Disease Vaccine Market: UNICEF (2017-2022) & (K Units) Figure 18. TB Disease Vaccine Consumed in Others Figure 19. Global TB Disease Vaccine Market: Others (2017-2022) & (K Units) Figure 20. Global TB Disease Vaccine Sales Market Share by Application (2017-2022) Figure 21. Global TB Disease Vaccine Revenue Market Share by Application in 2021 Figure 22. TB Disease Vaccine Revenue Market by Company in 2021 ($ Million) Figure 23. Global TB Disease Vaccine Revenue Market Share by Company in 2021 Figure 24. Global TB Disease Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 25. Global TB Disease Vaccine Revenue Market Share by Geographic Region in 2021 Figure 26. Global TB Disease Vaccine Sales Market Share by Region (2017-2022) Figure 27. Global TB Disease Vaccine Revenue Market Share by Country/Region in 2021 Figure 28. Americas TB Disease Vaccine Sales 2017-2022 (K Units) Figure 29. Americas TB Disease Vaccine Revenue 2017-2022 ($ Millions) Figure 30. APAC TB Disease Vaccine Sales 2017-2022 (K Units) Figure 31. APAC TB Disease Vaccine Revenue 2017-2022 ($ Millions) Figure 32. Europe TB Disease Vaccine Sales 2017-2022 (K Units) Figure 33. Europe TB Disease Vaccine Revenue 2017-2022 ($ Millions) Figure 34. Middle East & Africa TB Disease Vaccine Sales 2017-2022 (K Units) Figure 35. Middle East & Africa TB Disease Vaccine Revenue 2017-2022 ($ Millions) Figure 36. Americas TB Disease Vaccine Sales Market Share by Country in 2021 Figure 37. Americas TB Disease Vaccine Revenue Market Share by Country in 2021 Figure 38. United States TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 39. Canada TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 40. Mexico TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 41. Brazil TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 42. APAC TB Disease Vaccine Sales Market Share by Region in 2021 Figure 43. APAC TB Disease Vaccine Revenue Market Share by Regions in 2021 Figure 44. China TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. Japan TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. South Korea TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. Southeast Asia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 48. India TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 49. Australia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. Europe TB Disease Vaccine Sales Market Share by Country in 2021 Figure 51. Europe TB Disease Vaccine Revenue Market Share by Country in 2021 Figure 52. Germany TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. France TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. UK TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 55. Italy TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 56. Russia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 57. Middle East & Africa TB Disease Vaccine Sales Market Share by Country in 2021 Figure 58. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country in 2021 Figure 59. Egypt TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. South Africa TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Israel TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 62. Turkey TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 63. GCC Country TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 64. Manufacturing Cost Structure Analysis of TB Disease Vaccine in 2021 Figure 65. Manufacturing Process Analysis of TB Disease Vaccine Figure 66. Industry Chain Structure of TB Disease Vaccine Figure 67. Channels of Distribution Figure 68. Distributors Profiles
As the global economy mends, the 2021 growth of Dental Engine will have significant change from p ... Read More
As the global economy mends, the 2021 growth of Intravaginal Device will have significant change ... Read More
As the global economy mends, the 2021 growth of TCR-Based Antibody will have significant change f ... Read More
As the global economy mends, the 2021 growth of Vectorized Antibodies will have significant chang ... Read More